Tilray Brands Inc. closed 59.60% short of its 52-week high of $2.97, which the company reached on April 4th.

Pallas Capital Advisors LLC increased its holdings in shares of Tilray Inc (NASDAQ:TLRY – Free Report) by 59.4% during the fourth quarter, according to its most recent 13F filing with the Securities ...

Shares of Tilray Inc (NASDAQ:TLRY – Get Free Report) dropped 4.1% during mid-day trading on Monday following a weaker than expected earnings announcement. The stock traded as low as $1.16 and last ...

Following the company’s second quarter results, Haywood analyst Neal Gilmer has cut his price target on Tilray Brands ...

Breckenridge Brewery, a subsidiary of Tilray Brands, Inc. , is thrilled to introduce its new seasonal beer release, Spring Forward Grapefruit IPA. This vibrant brew masterfully balances bold ...

Tilray hopes that with legalization, it could export medical marijuana to the U.S. and capitalize on its infused beverage ...

Tilray reported gross profits of $61 million for Q2, ended November 30, a 29% gain over the previous year. Overall, net revenue was up 9% for the quarter, reaching $211 million. According to Tilray, ...

Tilray Brands, Inc. has recently released its 10-Q report, providing an in-depth look at the company's financial condition ...

Piper Sandler analyst Michael Lavery maintained a Hold rating on Tilray (TLRY – Research Report) today and set a price target of $2.00. The ...

Q2 2025 Earnings Call Transcript January 9, 2025 Operator: Thank you for joining us for today’s conference call to discuss ...

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...